The Evidence Brief
One concise briefing each week — new peptide trials, evidence-grade changes, and safety and legal updates, each inline-cited. No noise, only what the data shows.
- Signal, not hype One concise briefing each week — what the peptide evidence actually says, with the marketing claims set aside.
- Evidence-graded Every item ties to real trials and primary sources, with our A–D evidence grade and any change since last review.
- A five-minute read One clinical-grade edition. No noise, no clickbait, no inbox overwhelm.
Free · Weekly · Unsubscribe anytime · No spam.
What’s inside every edition
- A new or updated peptide monograph, and what changed
- New human-trial data we logged this week, with its grade
- Safety signals, purity recalls, and adverse-event notes
- Regulatory and legal updates (FDA, WADA, and beyond)